News

Nucleai and Merck KGaA Darmstadt, Germany Launch Translational Medicine Collaboration Utilizing Nucleai’s AI-Powered Biomarker Platform

Nucleai and Merck KGaA Darmstadt Germany announced a long-term collaboration to leverage Nucleai’s image analysis and biomarker discovery